Literature DB >> 29617940

Intraosseous Versus Intravenous Access in Pediatric Septic Shock Patients Admitted to Alexandria University Pediatric Intensive Care Unit.

Ahmed A El-Nawawy1, Omneya M Omar1, Mona Khalil1.   

Abstract

The cornerstone of emergency management of sepsis is early, goal-directed therapy. The purpose of this study was to evaluate the effect of intraosseous (IO) vs. intravenous (IV) access for resuscitation of patients with septic shock admitted to pediatric intensive care unit. This prospective interventional randomized clinical trial study was conducted on 60 patients with septic shock who need rapid administration of fluids and drugs; 30 cases were randomly chosen for IO vascular access, while the other 30 were selected for IV access. The IO route was successfully secured in all cases with a significant shorter time of vascular access insertion, shorter length of stay and reduction in mortality in IO group vs. IV group (p = 0.001, 0.045, 0.002, respectively). In pediatric emergencies, as in case of shock, the use of IO route is recommended to get rapid vascular access as soon as possible, as it revealed better outcome.

Entities:  

Mesh:

Year:  2018        PMID: 29617940     DOI: 10.1093/tropej/fmx061

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  3 in total

Review 1.  Sepsis in paediatrics.

Authors:  H D O'Reilly; K Menon
Journal:  BJA Educ       Date:  2020-12-07

Review 2.  Pediatric Critical Care in Resource Limited Settings-Lessening the Gap Through Ongoing Collaboration, Advancement in Research and Technological Innovations.

Authors:  Ashley Bjorklund; Tina Slusher; Louise Tina Day; Mariya Mukhtar Yola; Clark Sleeth; Andrew Kiragu; Arianna Shirk; Kristina Krohn; Robert Opoka
Journal:  Front Pediatr       Date:  2022-01-31       Impact factor: 3.418

3.  Is Humerus a Good Choice for Intraosseous Access During Fluid Resuscitation in a Child with Severe Septic Shock?

Authors:  Gökcan Öztürk; Burak Balaban; Tanıl Kendirli
Journal:  Turk Arch Pediatr       Date:  2022-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.